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Abstract
Multiple myeloma is an immunoproliferative monoclonal disorder of plasma cells, characterized by an expansion 
of atypical cells, which produce monoclonal immunoglobulin. This neoplasm has several clinical presentations: 
solitary osseous plasmacytoma, plasmocytic leukemia or extramedullary plasmocytoma. Plasmocytoma are rare in 
the gastrointestinal tract. This case present a histologically confirmed case of primary gastric plasmocytoma. 
Figure 1: Neoplastic infiltration is present in the stroma between the glands, 
and also partially destroys mucous membrane. Tumor cells were small, with 
eosynophylic cytoplasme and polymorphic nucleuses, with visible nucleoluses. 
H&E.
Introduction
Multiple myeloma (MM) is an immunoproliferative monoclonal 
disorder of plasma cells (plasmocytoma), characterized by an expansion 
of atypical cells, which produce monoclonal immunoglobulin (protein 
M). It presents as a discrete, solitary mass of neoplastic monoclonal 
plasma cells in either bone (most frequently) or more rarely, soft tissue 
MM constitutes about 1% of all malignant neoplasms with morbidity in 
Europe reported to be 4,5/100000/year and 5-years survival is 35% [1]. 
It affects more often males (M:F=2:1) and the age of presentation is ca. 
62 for men and 61 for women. 
Multiple myeloma has several clinical presentations: solitary 
osseous plasmacytoma (SOP; which is the most common), plasmocytic 
leukemia or extramedullary plasmocytoma (EMP) [2]. Primary EMPs 
(PEMPs) are rare, constituting fewer than 5% of all plasma cells 
neoplasms. Progression to disseminated plasma cell myeloma (PCM) is 
infrequent, occurs in approximately 15% of cases. 
Extramedullary plasmocytoma could be a solitary tumor localized 
in bone itself (6%) or outside the bones (2%) [3] especially in the soft 
tissues of the head and neck. Soft tissue plasmacytomas of the head 
and neck tend to involve the nasal cavity or nasopharynx, rather than 
the oral cavity [4]. Other localizations of EMP are rare and not well 
characterized in the literature. 
Primary gastric plasmocytoma is an extremely rare presentation of 
all extramedullary plasmocytoma. It constitutes 2-5% of EMCs. This 
type of tumor was described first time in 1928 year by Vasiliu i Popa 
[5], and since that time about 100 of new cases have been described 
[6]. This kind of tumor occurs in older patients with symptoms typical 
for GI tract disorders, such as weight loss, abdominal pain or upper 
gastrointestinal bleeding, which may delay diagnosis and treatment [5].
Clinical Presentation
87 years old man was admitted to the hospital with symptoms of 
fever reaching 38.5°C, lasting for several weeks and not responding 
to treatment. He also complained of weakness, night sweats, loss of 
appetite and dry cough. No other symptoms of malignancy were 
reported. Co-morbidities at the time of presentation included: coronary 
heart disease, hypertension, atrial fibrillation, COPD. 
In the laboratory results, mild normocytic anemia RBC 2.74 M/ul, 
Hgb 7.9 g/dl, HCT 23.6%, MCV 86.2 fL, WBC 7.2 K/ul, PLT 149.00 K/
ul), low level of iron (2.18 umol/l, ferritin 520 ug/l) increased level of 
ferritin and inflammatory markers (CRP 120,9 mg/l, fibrinogen 9 g/L 
) were observed. In routine urine analyses the proteinuria was present 
(0.3 g/l; while kidney function parameters such as creatinine, BUN 
were normal (creatinine 121.7 umol/l, BUN 9.3 mmol/l). In order to 
further address potential proteinuria, serum protein electrophoresis 
was performed but showed normal profile with no monoclonal protein 
present. Further diagnoses of fever of unknown origin included 
exclusion of all sites of inflammation were excluded (chest X-ray, 
USG of the abdomen, serial blood and urine cultures). Occult blood 
test in faeces was positive which led to subsequent gastroscopy and 
colonoscopy. The gastroscopy has indicated chronic inflammation of 
gastric mucosa (contain friable plaques in the whole stomach mucosa) 
with a small protrusion of mucosa (<5 mm) without ulceration. The 
urease test was negative. In the colonoscopy no abnormalities was found. 
Biopsies were taken of mucosal protrusion. In the histopathological 
analyses neoplastic infiltration of the gastric trunk was found, and after 
the immunological phenotyping multiple myeloma was diagnosed. 
The immunological phenotype was described: CD138+, LCA-, CK-, 
chromogranin -, CD68-, proteinogram S 100-, CD1a- (Figures 1 and 2). 
In the subsequent detailed urine analysis monoclonal light chain 
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immunoglobulin zone was found and in the blood high levels of free 
kappa chain 1310 mg/l were present (normal range: 3.3-19.4). The level 
of free chains lambda was normal 10.2 mg/l (n: 5.71–26.3). The ratio of 
free kappa to lambda chains was therefore highly increased to 128 (n: 
0.26–1.65). In most cases of plasmocytoma the plasmocytes synthesize 
complete M protein (pertained to IgG or IgA class), but in 10% of 
cases these cells produce light chains or their portions only. These are 
then secreted in the urine as a Bence-Jones protein. In such situation 
subtype of plasmocytoma: light chain disease is diagnosed (as it was 
in this case). Chest X-ray of flat bones revealed no osteolytic changes. 
Calcium levels: both total (2.17 mmol/l) and ionized (1.05 mmol/l) were 
normal. In bone marrow aspiration infiltration of plasmocytic cells was 
present in about 60–70%. In the past (about 10 years ago) patient had 
trepanobiopsy (because of pancytopenia) – no pathologic changes were 
found at that time. 
On the basis of these results and the clinical presentation the 
multiple myeloma subtype - light chain disease was diagnosed with 
the stomach involvment. Because of poor general condition and co-
morbidities (when diagnosis was made patient had severe congestive 
heart failure with hypotension) patient did not qualify for hematopoietic 
cell transplantation, but for therapy with systemic glycocortycosteroids. 
Apart from this, the patient was treated with antibiotics, anti-fungal 
drug and immunoglobulin. Despite of treatment patient died. 
Discussion  
Usually primary gastric EMP is diagnosed in elderly patients (like 
in this case), but there are no typical symptoms. Sometimes patients 
complain of pain or epigastric discomfort, weight loss or gastrointestinal 
bleeding. This patient’s main problem was fever and weakness. There 
was no obvious symptom of gastrointestinal bleeding, but occult blood 
test was positive. The differential diagnosis includes stomach carcinoma 
and other non-Hodgkin’s lymphomas like: lymphoplasmacytic 
lymphoma, follicular lymphoma, monocytoid B-cell lymphoma and 
mucosa-associated lymphoid tissue lymphomas (MALT).
In the literature there are some similar cases described. Esfandyari 
[7] presents a case of patient who was the same as in our patient a lesion 
in the stomach and involvement of the bone marrow. Their patient also 
was in advanced age. There were also changes in the stomach mucosa 
like friable plaques, but in our patient the tumor was also present. Gaur 
describes a patient with primary solitary bone plasmocytoma who 
had a gastric relapse of this tumor. The recurrence of the tumor took 
place after radiotherapy. What important at the beginning there was 
only tumor in vertebral column, but recurrence was present in bone 
marrow and stomach (but symptoms become from gastrointestinal 
tract – the same as in our case) [8]. On the basis of results we can’t 
arbitrate between the primary gastric plasmocytoma with progression 
to typical multiple myeloma or there was primary multiple myeloma 
with the same time infiltration of the stomach by plasmatic cells.
In published data surgical treatment [9], inclouding endoscopic 
submucosal dissection [10] or irradiation sometimes with chemotherapy 
is recommended. Surgical excision is recommended in all cases of 
extramedullary plasmocytomas, with one exception – extramedullary 
plasmocytomas with the head and neck localization [9]. In such situation 
radiotherapy alone is suggested [11]. If the tumor is excised without 
adequate surgical margin some authors recommend radiotherapy after 
the primary surgery [9,12]. Till now, there is no evidence that adjuvant 
chemotherapy is beneficial. There are some evidences that are good 
results of chemotherapy alone. In the literature there are different 
treatment plans: bortezomib alone, or bortezomib+dexamethasone 
[13]. But it seems that Helicobacter Pylori infection can have influence 
on the prognosis [14]. Eradication of this infection can cause regression 
of neoplastic changes localized in stomach [14] but it is not a role [15]. 
That patient had negative test for H. Pylori [16].
Light chain disease – plasmocytoma can have different prognosis: 
in about 15% of cases the progression to the typical tumor [16], in 
13% become disseminated extramedullary plasmocytoma, in 7% 
of cases local lymph nodes became affected. Most patients with an 
extramedullary plasmocytomas die because of unrelated causes [17].
Clinical Practice Points
Primary gastric EMP can have different clinical presentation. Not 
necessarily symptoms include gastrointestinal bleeding; sometimes 
fever could be the only symptom. What is important the size of the 
primary tumour is not a good predictor of increased risk of progression 
to the typical tumour and dissemination? In this case, despite of small 
size of tumour in the stomach the medullary involvement is present.
When we have patient with FUO (fever of unknown origin) we 
have to think about neoplasm (including plasmocytoma even if the 
protein electrophoresis is unchanged). 
Conclusion
We have reported here a case of elderly patients in whom multiple 
myeloma initially localized to gastric mucosa rapidly progressed to 
systemic disease leading to patient’s death. It is therefore important 
to include plasmocytoma in the differential diagnosis of atypical 
presentation of gastric tumours even in the absence of other symptoms 
of multiple myeloma.
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